EUVIMEDEUVIMED entdecken
Crossref

In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy

Seonwoo Kang, Yeoul Kang, Yelim Lee, Jaehyun Park, Junseok Lee iD, Won Jong Kim iD

ACS Nano · 2025

DOI: 10.1021/acsnano.5c08128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Seonwoo Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Repu…. Hauptthemen laut MEDLINE: Immunotherapy, Immunoglobulin Fc Fragments, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Evaluation Institute of Industrial Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells exert potent cytotoxic effects by releasing perforin, granzyme B, and immune-boosting cytokines upon recognition of antibody-coated targets. However, the heterogeneous expression of tumor antigens poses a major limitation to NK-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). To overcome this challenge, we developed a Universal Antibody (Univody), a recombinant fusion protein that enables an antigen-independent presentation of Fc fragments on the surface of cancer cells. Specifically, the Fc region of human IgG1 was fused with a transmembrane domain and delivered in the form of plasmid DNA, ensuring stable membrane localization and interaction with NK cell receptors. For efficient and selective delivery, we employed a phenylboronic acid (PBA)-modified lipopolyplex (LPP-PBA), which significantly enhanced cellular uptake and transfection efficiency while reducing cytotoxicity. The plasmid DNA encoding Univody (pUnivody) effectively decorated a variety of heterogeneous tumor types with Fc fragments, leading to NK cell activation and enhanced immune responses in the tumor microenvironment. In vivo, pUnivody@LPP-PBA treatment resulted in marked tumor inhibition in both triple-negative breast cancer and melanoma models. This antigen-independent platform broadens the scope of antibody therapy and immunotherapy, offering a versatile approach to treating multiple types of cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyImmunoglobulin Fc FragmentsNeoplasmsHumansAnimalsKiller Cells, NaturalMiceCell Line, TumorFemaleBoronic Acids

Stichwörter der Autor:innen

antibody therapeuticscancergene deliveryimmunotherapynanoparticle

Substanzen

benzeneboronic acidImmunoglobulin Fc FragmentsBoronic Acids

Autor:innen und Institutionen

  • Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
  • Department of Molecular and Medical Pharmacology, California NanoSystems Institute (CNSI), Crump Institute for Molecular Imaging, University of California (UCLA) Los Angeles, 570 Westwood Plaza, Los Angeles, California…
  • OmniaMed Co, Ltd., Pohang 37673, Republic of Korea.

ORCID-Profile: Junseok Lee, Won Jong Kim

Förderung

  • National Research Foundation of Korea
  • Korea Evaluation Institute of Industrial Technology

Zitieren

APA

Kang, S., Kang, Y., Lee, Y., Park, J., Lee, J., & Kim, W. J. (2025). In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.5c08128

Vancouver

Kang S, Kang Y, Lee Y, Park J, Lee J, Kim WJ. In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy. ACS Nano. 2025. doi:10.1021/acsnano.5c08128

BibTeX
@article{Kang2025,
  author = {Kang, Seonwoo and Kang, Yeoul and Lee, Yelim and Park, Jaehyun and Lee, Junseok and Kim, Won Jong},
  title = {In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.5c08128}
}
Kostenlos starten →